Home › Funds › Creek Drive Management Group LLC › RNA

Creek Drive Management Group LLC position in RNA

ATRIUM THERAPEUTICS INC · Health Care

Creek Drive Management Group LLC reported holding 127,600 shares of RNA (ATRIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.7M, representing 0.98% of its reported portfolio and ranking #28 among its reported holdings. Creek Drive Management Group LLC has disclosed RNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)127.60K sh
Reported value held$1.72M
Portfolio Weight0.98%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Creek Drive Management Group LLC's RNA position evolved

Creek Drive Management Group LLC first disclosed a stake in RNA in Q1 2026 at 120,000 shares (US$1.6M). The position peaked in Q2 2026 at 127,600 shares, worth US$1.7M. Across 2 filings, Creek Drive Management Group LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 127,600 shares valued at US$1.7M — an increase of 7,600 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 120.00K $1.60M New
Q2 2026 127.60K $1.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RNA and 13F data

RNA (ATRIUM THERAPEUTICS INC) is a Health Care company. 116 other funds we track also report a position in RNA — the largest reported positions include Sessa Capital IM, L.P. (US$20.2M), CRCM LP (US$8.6M), TIG Advisors, LLC (US$7.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RNA

All RNA fund holders →

FAQ

How long has Creek Drive Management Group LLC held RNA?

Creek Drive Management Group LLC has disclosed RNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Creek Drive Management Group LLC's current position in RNA?

As of Q2 2026, Creek Drive Management Group LLC holds 127.60K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $1.72M, representing 0.98% of its reported portfolio and ranking #28.

Has Creek Drive Management Group LLC been buying or selling RNA?

In the latest 13F filing (Q2 2026), Creek Drive Management Group LLC increased its position in RNA. The position peaked in Q2 2026 at 127.60K shares.

Which other funds hold RNA?

Other major institutional holders of RNA include Sessa Capital IM, L.P., CRCM LP, TIG Advisors, LLC, among 116 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.